跳至主要内容
临床试验/KCT0008697
KCT0008697招募中Unknown

Effective site concentration of remifentanil inhibiting hemodynamic response following endotracheal intubation using videolaryngoscope during induction with remimazolam

Bundang CHA General Hospital0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
19(Year) 至 65(Year)(—)
性别
All

入选标准

  • Korean patients between the ages of 19 and 65 who are classified as American Society of Anesthesiology Classes 1 and 2 under general anesthesia

排除标准

  • Allergy to study drug, acute narrow-angle glaucoma, sleep apnea syndrome, alcohol or drug dependence, galactose or lactase deficiency, dextran 40 hypersensitivity, heart, lung, kidney, liver, cerebrovascular system, Psychiatric patients, pregnant women, lactating women, foreigners, others American Society of Anesthesiologists Body Classification 3 or higher

研究者

发起方
Bundang CHA General Hospital

相似试验

Effective site concentration of remifentanil... | 临床试验